Similar Papers

Paper Title
Journal
Date
Author
The MRC Randomised-controlled Trial of Interferon-α, Interleukin-2 and 5-Fluorouracil vs Interferon-α Alone in Patients with Advanced Renal cell Carcinoma (RE04): Rationale and Progress
J.M.G Larkin ... M.E Gore
Clinical Oncology | VOL. 17
J.M.G Larkin, et. al.J.M.G Larkin ... M.E Gore
01 Aug 2005
Focus on kidney cancer
W.Marston Linehan ... Berton Zbar
Cancer Cell | VOL. 6
W.Marston Linehan, et. al.W.Marston Linehan ... Berton Zbar
01 Sep 2004
Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial
T Klatte ... M Böhm
British Journal of Cancer | VOL. 95
T Klatte, et. al.T Klatte ... M Böhm
10 Oct 2006
USING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Hyung L Kim ... Robert A Figlin
Journal of Urology | VOL. 173
Hyung L Kim, et. al.Hyung L Kim ... Robert A Figlin
01 May 2005
View more papers

More From: Yearbook of Urology

Paper Title
Journal
Date
Author
De novo erectile dysfunction after anterior urethroplasty: a systematic review and meta-analysis
A.W Shindel
Yearbook of Urology | VOL. 2014
A.W ShindelA.W Shindel
01 Jan 2014
Outcomes of Incontinent Ileovesicostomy in the Pediatric Patient
D.E Coplen
Yearbook of Urology | VOL. 2014
D.E CoplenD.E Coplen
01 Jan 2014
OnabotulinumtoxinA 100U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
E.S Rovner
Yearbook of Urology | VOL. 2014
E.S RovnerE.S Rovner
01 Jan 2014
Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12Years of Follow-up
A.S Kibel
Yearbook of Urology | VOL. 2014
A.S KibelA.S Kibel
01 Jan 2014
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.